Daratumumab (Dara) is the first-in-class human-specific anti-CD38 mAb approved for the treatment of multiple myeloma (MM). Although recent data have demonstrated very promising results in clinical practice and trials, some patients do not achieve a partial response, and ultimately all patients undergo progression. Dara exerts anti-MM activity via antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC), and immunomodulatory effects. Deregulation of these pleiotropic mechanisms may cause development of Dara resistance. Knowledge of this resistance may improve the therapeutic management of MM patients

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma

Saltarella, Ilaria;Desantis, Vanessa;Melaccio, Assunta;Solimando, Antonio Giovanni;Lamanuzzi, Aurelia;Ria, Roberto;Storlazzi, Clelia Tiziana;Mariggiò, Maria Addolorata;Vacca, Angelo
;
2020-01-01

Abstract

Daratumumab (Dara) is the first-in-class human-specific anti-CD38 mAb approved for the treatment of multiple myeloma (MM). Although recent data have demonstrated very promising results in clinical practice and trials, some patients do not achieve a partial response, and ultimately all patients undergo progression. Dara exerts anti-MM activity via antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC), and immunomodulatory effects. Deregulation of these pleiotropic mechanisms may cause development of Dara resistance. Knowledge of this resistance may improve the therapeutic management of MM patients
File in questo prodotto:
File Dimensione Formato  
101.pdf

accesso aperto

Descrizione: Articolo in rivista
Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 707.53 kB
Formato Adobe PDF
707.53 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/255758
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 78
  • ???jsp.display-item.citation.isi??? 71
social impact